Published in Curr Treat Options Cardiovasc Med on April 14, 2010
Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc (2016) 0.87
Treatment for critical lower limb ischemia in elderly patients. World J Surg (2012) 0.83
Monocytic adhesion molecule expression and monocyte-endothelial cell dysfunction are increased in patients with peripheral vascular disease versus patients with abdominal aortic aneurysms. J Surg Res (2012) 0.77
Assessment of effectiveness of endovascular treatment of common and external iliac artery stenosis/occlusion using self-expanding Jaguar SM stents. Pol J Radiol (2012) 0.76
Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic Rats. PLoS One (2015) 0.75
Management of critical limb ischemia. Can Fam Physician (2012) 0.75
Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia. J Vasc Surg (2014) 0.75
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg (2007) 14.17
Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med (1992) 8.94
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med (1996) 7.26
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet (2002) 7.11
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg (2006) 3.38
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med (2008) 3.21
A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg (2007) 2.96
Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation (2008) 2.82
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg (2008) 2.55
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg (2009) 2.55
Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J (2002) 2.38
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J (1999) 2.08
Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg (2009) 1.86
The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis (1991) 1.84
National health care costs of peripheral arterial disease in the Medicare population. Vasc Med (2008) 1.83
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.71
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J (2004) 1.64
Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg (2008) 1.60
Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg (2008) 1.50
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg (2010) 1.47
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg (2008) 1.47
Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg (2006) 1.28
Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg (2005) 1.26
Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther (2002) 1.26
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther (2006) 1.22
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord (2005) 1.18
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg (2009) 1.14
Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg (2007) 1.12
Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg (2006) 1.11
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg (2010) 1.08
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg (2010) 1.08
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg (2010) 1.06
Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg (2006) 1.05
Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg (2008) 1.05
Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J (2005) 1.04
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg (2007) 1.03
Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg (1989) 1.01
The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg (2007) 1.01
Predicting ambulation status one year after lower extremity bypass. J Vasc Surg (2009) 1.01
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg (2010) 1.00
Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther (2006) 1.00
Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg (2005) 0.98
Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg (2007) 0.96
AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol (2008) 0.95
Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg (2008) 0.95
Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg (2009) 0.94
Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg (2007) 0.93
Regenerative medicine in the treatment of peripheral arterial disease. J Cell Biochem (2009) 0.93
Redo infrainguinal bypass: factors predicting patency and limb salvage. Ann Vasc Surg (2003) 0.90
Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol (2004) 0.88
Angiographic scoring of vascular occlusive disease in the diabetic foot: relevance to bypass graft patency and limb salvage. J Vasc Surg (2002) 0.88
Nitinol stenting for treatment of ''below-the-knee'' critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg (Torino) (2007) 0.86
Cost per day of patency: understanding the impact of patency and reintervention in a sustainable model of healthcare. J Vasc Surg (2008) 0.85
Hemodynamic effects of intermittent pneumatic compression in patients with critical limb ischemia. J Vasc Surg (2005) 0.82
Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev (2003) 0.81
Advances on drug-coated balloons. J Cardiovasc Surg (Torino) (2010) 0.79
Prediction of the immediate outcome of femoropopliteal saphenous vein bypass by angiographic runoff score. Eur J Vasc Endovasc Surg (1998) 0.76
Potential solutions to the current problem: coated balloon. EuroIntervention (2008) 0.76
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg (2012) 2.78
The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg (2008) 2.55
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res (2002) 2.53
Peripheral arterial interventions: trends in market share and outcomes by specialty, 1998-2005. J Vasc Surg (2009) 2.20
Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg (2013) 2.16
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg (2006) 2.14
Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg (2009) 1.86
Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation (2008) 1.80
Carotid artery stenting has increased rates of postprocedure stroke, death, and resource utilization than does carotid endarterectomy in the United States, 2005. J Vasc Surg (2008) 1.78
Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia. J Vasc Surg (2013) 1.72
Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg (2012) 1.53
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol (2010) 1.47
Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg (2008) 1.47
An analysis of carotid artery stenting procedures performed in New York and Florida (2005-2006): procedure indication, stroke rate, and mortality rate are equivalent for vascular surgeons and non-vascular surgeons. J Vasc Surg (2009) 1.44
Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med (2002) 1.42
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease. J Vasc Surg (2013) 1.42
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg (2010) 1.34
Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation. J Vasc Surg (2008) 1.21
Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness. J Vasc Surg (2006) 1.19
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16
National trends in utilization and postprocedure outcomes for carotid artery revascularization 2005 to 2007. J Vasc Surg (2010) 1.15
Clinical results of carotid artery stenting compared with carotid endarterectomy. J Vasc Surg (2008) 1.15
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg (2009) 1.14
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg (2011) 1.13
D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. FASEB J (2013) 1.12
Endovascular treatment of ruptured abdominal aortic aneurysms in the United States (2001-2006): a significant survival benefit over open repair is independently associated with increased institutional volume. J Vasc Surg (2009) 1.12
Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. J Vasc Surg (2004) 1.09
Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg (2007) 1.09
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg (2010) 1.08
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg (2009) 1.05
Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation (2012) 1.04
Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke. J Vasc Surg (2010) 1.04
Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg (2004) 1.03
Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg (2006) 1.03
Surgeon case volume, not institution case volume, is the primary determinant of in-hospital mortality after elective open abdominal aortic aneurysm repair. J Vasc Surg (2010) 1.03
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg (2007) 1.03
Outcomes of symptomatic abdominal aortic aneurysm repair. J Vasc Surg (2010) 1.02
Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. Arterioscler Thromb Vasc Biol (2005) 1.01
Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg (2004) 1.01
Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg (2005) 1.00
Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling. J Vasc Surg (2004) 0.99
Comparison of carotid endarterectomy and stenting in real world practice using a regional quality improvement registry. J Vasc Surg (2012) 0.98
Preoperative risk factors for carotid endarterectomy: defining the patient at high risk. J Vasc Surg (2003) 0.96
In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE. Magn Reson Med (2009) 0.96
Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg (2007) 0.96
Predicting functional status following amputation after lower extremity bypass. Ann Vasc Surg (2012) 0.95
Lower extremity vein graft failure: a translational approach. Vasc Med (2008) 0.95
Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease. J Vasc Access (2011) 0.94
Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg (2004) 0.94
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. J Vasc Surg (2005) 0.94
Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg (2009) 0.94
Clinical practice. Acute limb ischemia. N Engl J Med (2012) 0.93
Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. J Vasc Surg (2010) 0.93
Variation in smoking cessation after vascular operations. J Vasc Surg (2013) 0.92
Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg (2011) 0.92
Upper arm arteriovenous fistula versus forearm looped arteriovenous graft for hemodialysis access: a comparative analysis. Ann Vasc Surg (2005) 0.91
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.91
Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion. J Surg Res (2012) 0.90
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol (2016) 0.90
Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg (2006) 0.90
In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. J Vasc Surg (2009) 0.89
n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial. Vasc Med (2013) 0.89
High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE. Magn Reson Med (2008) 0.89
Growing impact of restenosis on the surgical treatment of peripheral arterial disease. J Am Heart Assoc (2013) 0.89
C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta. Am J Physiol Heart Circ Physiol (2008) 0.88
Setting high-impact clinical research priorities for the Society for Vascular Surgery. J Vasc Surg (2013) 0.88
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. Am Heart J (2012) 0.88
Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study. Vasc Med (2013) 0.86
Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm. J Vasc Surg (2003) 0.86
Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts. Int J Cardiovasc Imaging (2010) 0.86
Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules. Sci Rep (2013) 0.86
The effect of postoperative stroke and myocardial infarction on long-term survival after carotid revascularization. J Vasc Surg (2013) 0.86
Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair. J Vasc Surg (2009) 0.86
Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art. Circulation (2008) 0.86
The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg (2003) 0.85
Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. J Vasc Surg (2009) 0.85
Medical management of peripheral arterial disease: bridging the "gap"? Circulation (2012) 0.84
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease. J Vasc Surg (2013) 0.84
Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. J Vasc Surg (2012) 0.84
Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging. Int J Cardiovasc Imaging (2007) 0.84
Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia. Ann Vasc Surg (2013) 0.84
Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein. J Vasc Surg (2002) 0.83
Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures. Am J Surg (2008) 0.83
Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation. Circ Cardiovasc Interv (2013) 0.83
Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. Am J Physiol Heart Circ Physiol (2011) 0.83
Outcomes of lower extremity bypass performed for acute limb ischemia. J Vasc Surg (2013) 0.82
An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. J Vasc Surg (2012) 0.82
Polyunsaturated fatty acids and peripheral artery disease. Vasc Med (2012) 0.82
Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg (2015) 0.82
RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2011) 0.81
Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice. J Thorac Cardiovasc Surg (2012) 0.81
Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures? Semin Vasc Surg (2008) 0.81